Survey to Evaluate the Effectiveness of Risk Minimisation Measures for Atezolizumab Use in the European Union

07/12/2017
02/07/2024
EU PAS number:
EUPAS21920
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

WO40486_Protocol_11 Dec 2018_Redacted

English (1.58 MB - PDF) View document
Updated protocol

Prot WO40486 Tecentriq v1_Redacted

First published: 22/02/2024
English (1.85 MB - PDF) View document
Study results
Study results

Final_CSR_Study_WO40486__Published_Output-1_CSR_Synopsis_Redacted

English (1.08 MB - PDF) View document
Study report
Other information